Metabolic syndrome: This term refers to a cluster of conditions that occur together, increasing the risk of heart disease, stroke, and type 2 diabetes. It typically includes high blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levels.. Metabolic syndrome
Conditions
Interventions
The intervention group in this study will receive a nurse-led low carbohydrate regimen, which includes the following components:
Sponsors
College of Nursing, University of Baghdad
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Age: Specify the age range of participants 18 to 70. Diagnosis of Metabolic Syndrome: Participants should have a confirmed diagnosis of metabolic syndrome based on specific criteria as defined by the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) Participants must provide informed consent
Exclusion criteria
Exclusion criteria: Exclude pregnant or lactating women Exclude individuals with severe medical conditions. Exclude individuals who are currently participating in other clinical trials that could interfere with the study. Exclude individuals who are unable or unwilling to adhere to the prescribed low carbohydrate dietary regimen. Exclude individuals with severe mental health issues that could affect their ability to participate or comply with the study requirements. Exclude individuals taking medications or supplements that could significantly affect metabolism or interfere with the study's dietary intervention.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome variable for this study is the change metabolic parameters as the following 1. Waist Circumference: Measurement of abdominal obesity 2. Blood Pressure: Assessment of elevated blood pressure, often defined as systolic blood pressure = 130 mm Hg or diastolic blood pressure = 85 mm Hg. 3. Fasting Blood Glucose: Measurement of fasting blood sugar levels, with elevated levels indicating impaired glucose metabolism. 4. Triglycerides: Evaluation of triglyceride levels in the blood, with elevated levels considered a risk factor. 5. High-Density Lipoprotein (HDL) Cholesterol: Measurement of HDL cholesterol, with lower levels considered a risk factor 6. .Low-Density Lipoprotein (LDL) Cholesterol: Assessment of LDL cholesterol, another important lipid parameter. 7. Insulin Resistance: Calculation or measurement of insulin resistance, often done using the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR). 8. Body Mass Index (BMI): Calculation of BMI, which provides an overall measure of obesity. Timepoint: Before intervention and 1,3 month after intervention. Method of measurement: 1.Waist circumference: Waist circumference will be measured using a flexible measuring tape. Participants will be asked to stand up and the tape will be placed around the waist at the level of the navel. The measurement will be recorded in centimeters (cm). 2.Blood pressure: Blood pressure will be measured using an automated sphygmomanometer. Participants will be comfortably seated with their arms supported at heart level. Blood pressure will be taken in triplicate and the average of the second and third readings will be recorded. 3.Fasting blood glucose: Fasting blood glucose levels will be measured using a standard glucose meter. Participants will be asked to fast for at least 8 hours before the test and a blood sample will be taken from a fingerstick. | — |
Countries
Iraq
Contacts
Public ContactMohammed Faris Abdulghani
University of Baghdad, College of Nursing
Outcome results
None listed